Neuropeptides
Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia
Medvedev VE, Tereshchenko OE, Israelyan AY, et al. · Zh Nevrol Psikhiatr Im S S Korsakova · 2007
PMID: 18454096
Summary
Clinical comparison study (n=62) of intranasal selank vs medazepam in generalized anxiety disorder and neurasthenia. Endpoints: Hamilton anxiety scale, Zung, CGI; plasma leu-enkephalin.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
Compounds referenced in this study
- View product →SelankSynthetic tuftsin analog studied in anxiolytic and immunomodulatory research literature.
Guides covering this compound
More Neuropeptides citations
- Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled TrialsNeurol Sci · 2018
- Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trialStroke · 2012
- The efficacy of semax in the treatment of patients at different stages of ischemic strokeZh Nevrol Psikhiatr Im S S Korsakova · 2018